remeglurant remeglurant remeglurant (inn; developmental code name mrz-8456) is a drug which acts as a selective antagonist of the mglu5 receptor. it is under development by merz pharmaceuticals for the treatment of drug-induced dyskinesia but no development has been reported since at least 2016. remeglurantclinical dataother namesmrz-8456atc codenoneidentifiers iupac name (6-bromopyrazolopyrimidin-2-yl)methanone cas number1309783-00-3pubchem cid24810684chemspider32701693uniiy7h8880hmdchemical and physical dataformulac17h15brn4omolar mass371.238 g·mol−13d model (jsmol)interactive image smiles c1c2ccccc2ccn1c(=o)c3cc4ncc(cn4n3)br inchi inchi=1s/c17h15brn4o/c1-11-14-5-3-2-4-12(14)6-7-21(11)17(23)15-8-16-19-9-13(18)10-22(16)20-15/h2-5,8-11h,6-7h2,1h3/t11-/m1/s1key:tuyzysnxxstkqx-llvkdonjsa-n